5th Scientific Drug Delivery Conference

Live Conference on FORMULATION DEVELOPMENT and TECHNOLOGIES

Feb. 07th, 2024 This 1-day conference is an excellent opportunity for R&D Managers, Technology Experts and Business Development Managers who have specific interest in up-to-date formulation technologies and their special aspects in formulation and analytical development.

View Agenda DDC 2024

What are the benefits of this Drug Delivery Conference?

International experts and guest speakers from industry and academia will be presenting relevant topics as well as the most current case studies.

The agenda will provide room for expert discussions and exchanging know-how. Participants will also be able to directly apply their learnings from this symposium to their daily work. For any questions, please contact ddcffm@losan.de

Losan Pharma company

View our AGENDA 2024

DDC 2024 conference

Wednesday, 7th of February 2024

9:30
Registration & Welcome Coffee
10:00
Welcome & Introduction

Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH, 
Dr. François Boutignon, APTYS Pharmaceuticals

10:20
“QbCon – a new drying technology for sensitive drugs”

Dr. Robin Meier, L.B. Bohle Maschinen und Verfahren GmbH

10:50
„The roadmap to ivivc for ASD formulations“

Prof. Thomas Rades, Prof. Anette Muellertz, University of Copenhagen

11:20
Coffee Break
11:40
„Amorphous solid dispersions for PROTAC molecules“

Dr. Meike Harms, Merck Healthcare KGaA

12:10
„Wet ball milling: a toolbox for various applications to improve bioavailability“

Dr. Wolfgang Mohr / Dr. Matthias Rischer, Losan Pharma GmbH

12:40
Lunch
14:00
„3D printing – from development to GMP“

Dr. Anja Stulz / Dr. Ansgar Bögershausen, Losan Pharma GmbH

14:30
„Development of in vivo relevant QC dissolution methods“

Dr. Jochen Scher, Boehringer Ingelheim Pharma GmbH & Co. KG

15:00
Coffee Break
15:20
„Nanoformulation for enhanced drug delivery and better patient compliance“

Dr. Michael Black, Beneo GmbH

15:50
„Microfluidic nanoparticulate encapsulation method for novel drug substances“

Dr. Johannes Büscher, University of Saarland / Boehringer Ingelheim Pharma GmbH & Co. KG

16:20
Summary and Apéro

Dr. Jens Morgenthaler, General Manager Losan Pharma GmbH

Overview Losan DDC 2024

Date

February 07th, 2024
9:30 – 16:45

Participation fee

300 €

live conference

Frankfurt City, Flemings’ Select Hotel

Symposium language

English

Chairman

Dr. François Boutignon, President & CEO APTYS Pharmaceuticals

Co Chairman
Dr. Matthias Rischer, Losan Pharma GmbH

Registration

Registration is closed

Nanomill Losan Pharma
Nanomilling processes at Losan Pharma
nanomill at Losan Pharma
Producing Nanosuspensions at Losan Pharma